0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global CAR-T Therapy Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-34L13513
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global CAR T Therapy Market Research Report 2023
BUY CHAPTERS

Global CAR-T Therapy Market Research Report 2025

Code: QYRE-Auto-34L13513
Report
September 2025
Pages:81
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

CAR-T Therapy Market

The global market for CAR-T Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for CAR-T Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for CAR-T Therapy is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for CAR-T Therapy in Acute Lymphocytic Leukemia is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of CAR-T Therapy include Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Atara Biotherapeutics, Aurora Biopharma, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for CAR-T Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CAR-T Therapy.
The CAR-T Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CAR-T Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CAR-T Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of CAR-T Therapy Market Report

Report Metric Details
Report Name CAR-T Therapy Market
Segment by Type
  • CD19
  • CD22
  • Other
Segment by Application
  • Acute Lymphocytic Leukemia
  • Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Chronic Lymphocytic Leukemia
  • Multiple Myeloma
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Atara Biotherapeutics, Aurora Biopharma, Autolus Therapeutics PLC, Bluebird, Carina Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of CAR-T Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the CAR-T Therapy Market report?

Ans: The main players in the CAR-T Therapy Market are Novartis AG, Kite Pharma, Pfizer, Juno Therapeutics, Celgene Corporation, CARsgen Therapeutics, Sorrento Therapeutics, Legend Biotech, Atara Biotherapeutics, Aurora Biopharma, Autolus Therapeutics PLC, Bluebird, Carina Biotech

What are the Application segmentation covered in the CAR-T Therapy Market report?

Ans: The Applications covered in the CAR-T Therapy Market report are Acute Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Chronic Lymphocytic Leukemia, Multiple Myeloma, Other

What are the Type segmentation covered in the CAR-T Therapy Market report?

Ans: The Types covered in the CAR-T Therapy Market report are CD19, CD22, Other

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CAR-T Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 CD19
1.2.3 CD22
1.2.4 Other
1.3 Market by Application
1.3.1 Global CAR-T Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Acute Lymphocytic Leukemia
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Follicular Lymphoma
1.3.5 Chronic Lymphocytic Leukemia
1.3.6 Multiple Myeloma
1.3.7 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CAR-T Therapy Market Perspective (2020-2031)
2.2 Global CAR-T Therapy Growth Trends by Region
2.2.1 Global CAR-T Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CAR-T Therapy Historic Market Size by Region (2020-2025)
2.2.3 CAR-T Therapy Forecasted Market Size by Region (2026-2031)
2.3 CAR-T Therapy Market Dynamics
2.3.1 CAR-T Therapy Industry Trends
2.3.2 CAR-T Therapy Market Drivers
2.3.3 CAR-T Therapy Market Challenges
2.3.4 CAR-T Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CAR-T Therapy Players by Revenue
3.1.1 Global Top CAR-T Therapy Players by Revenue (2020-2025)
3.1.2 Global CAR-T Therapy Revenue Market Share by Players (2020-2025)
3.2 Global CAR-T Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CAR-T Therapy Revenue
3.4 Global CAR-T Therapy Market Concentration Ratio
3.4.1 Global CAR-T Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CAR-T Therapy Revenue in 2024
3.5 Global Key Players of CAR-T Therapy Head office and Area Served
3.6 Global Key Players of CAR-T Therapy, Product and Application
3.7 Global Key Players of CAR-T Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CAR-T Therapy Breakdown Data by Type
4.1 Global CAR-T Therapy Historic Market Size by Type (2020-2025)
4.2 Global CAR-T Therapy Forecasted Market Size by Type (2026-2031)
5 CAR-T Therapy Breakdown Data by Application
5.1 Global CAR-T Therapy Historic Market Size by Application (2020-2025)
5.2 Global CAR-T Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CAR-T Therapy Market Size (2020-2031)
6.2 North America CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CAR-T Therapy Market Size by Country (2020-2025)
6.4 North America CAR-T Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CAR-T Therapy Market Size (2020-2031)
7.2 Europe CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CAR-T Therapy Market Size by Country (2020-2025)
7.4 Europe CAR-T Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CAR-T Therapy Market Size (2020-2031)
8.2 Asia-Pacific CAR-T Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CAR-T Therapy Market Size (2020-2031)
9.2 Latin America CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CAR-T Therapy Market Size by Country (2020-2025)
9.4 Latin America CAR-T Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CAR-T Therapy Market Size (2020-2031)
10.2 Middle East & Africa CAR-T Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG CAR-T Therapy Introduction
11.1.4 Novartis AG Revenue in CAR-T Therapy Business (2020-2025)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Details
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma CAR-T Therapy Introduction
11.2.4 Kite Pharma Revenue in CAR-T Therapy Business (2020-2025)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer CAR-T Therapy Introduction
11.3.4 Pfizer Revenue in CAR-T Therapy Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Details
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics CAR-T Therapy Introduction
11.4.4 Juno Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Details
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation CAR-T Therapy Introduction
11.5.4 Celgene Corporation Revenue in CAR-T Therapy Business (2020-2025)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Details
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics CAR-T Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Details
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics CAR-T Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Details
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech CAR-T Therapy Introduction
11.8.4 Legend Biotech Revenue in CAR-T Therapy Business (2020-2025)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Details
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics CAR-T Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in CAR-T Therapy Business (2020-2025)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Details
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma CAR-T Therapy Introduction
11.10.4 Aurora Biopharma Revenue in CAR-T Therapy Business (2020-2025)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Details
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC CAR-T Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2020-2025)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Details
11.12.2 Bluebird Business Overview
11.12.3 Bluebird CAR-T Therapy Introduction
11.12.4 Bluebird Revenue in CAR-T Therapy Business (2020-2025)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Details
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech CAR-T Therapy Introduction
11.13.4 Carina Biotech Revenue in CAR-T Therapy Business (2020-2025)
11.13.5 Carina Biotech Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global CAR-T Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of CD19
 Table 3. Key Players of CD22
 Table 4. Key Players of Other
 Table 5. Global CAR-T Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global CAR-T Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global CAR-T Therapy Market Share by Region (2020-2025)
 Table 9. Global CAR-T Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global CAR-T Therapy Market Share by Region (2026-2031)
 Table 11. CAR-T Therapy Market Trends
 Table 12. CAR-T Therapy Market Drivers
 Table 13. CAR-T Therapy Market Challenges
 Table 14. CAR-T Therapy Market Restraints
 Table 15. Global CAR-T Therapy Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global CAR-T Therapy Market Share by Players (2020-2025)
 Table 17. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2024)
 Table 18. Ranking of Global Top CAR-T Therapy Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by CAR-T Therapy Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of CAR-T Therapy, Headquarters and Area Served
 Table 21. Global Key Players of CAR-T Therapy, Product and Application
 Table 22. Global Key Players of CAR-T Therapy, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global CAR-T Therapy Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global CAR-T Therapy Revenue Market Share by Type (2020-2025)
 Table 26. Global CAR-T Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global CAR-T Therapy Revenue Market Share by Type (2026-2031)
 Table 28. Global CAR-T Therapy Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global CAR-T Therapy Revenue Market Share by Application (2020-2025)
 Table 30. Global CAR-T Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global CAR-T Therapy Revenue Market Share by Application (2026-2031)
 Table 32. North America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific CAR-T Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific CAR-T Therapy Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific CAR-T Therapy Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa CAR-T Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa CAR-T Therapy Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa CAR-T Therapy Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Novartis AG Company Details
 Table 48. Novartis AG Business Overview
 Table 49. Novartis AG CAR-T Therapy Product
 Table 50. Novartis AG Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 51. Novartis AG Recent Development
 Table 52. Kite Pharma Company Details
 Table 53. Kite Pharma Business Overview
 Table 54. Kite Pharma CAR-T Therapy Product
 Table 55. Kite Pharma Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 56. Kite Pharma Recent Development
 Table 57. Pfizer Company Details
 Table 58. Pfizer Business Overview
 Table 59. Pfizer CAR-T Therapy Product
 Table 60. Pfizer Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 61. Pfizer Recent Development
 Table 62. Juno Therapeutics Company Details
 Table 63. Juno Therapeutics Business Overview
 Table 64. Juno Therapeutics CAR-T Therapy Product
 Table 65. Juno Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 66. Juno Therapeutics Recent Development
 Table 67. Celgene Corporation Company Details
 Table 68. Celgene Corporation Business Overview
 Table 69. Celgene Corporation CAR-T Therapy Product
 Table 70. Celgene Corporation Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 71. Celgene Corporation Recent Development
 Table 72. CARsgen Therapeutics Company Details
 Table 73. CARsgen Therapeutics Business Overview
 Table 74. CARsgen Therapeutics CAR-T Therapy Product
 Table 75. CARsgen Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 76. CARsgen Therapeutics Recent Development
 Table 77. Sorrento Therapeutics Company Details
 Table 78. Sorrento Therapeutics Business Overview
 Table 79. Sorrento Therapeutics CAR-T Therapy Product
 Table 80. Sorrento Therapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 81. Sorrento Therapeutics Recent Development
 Table 82. Legend Biotech Company Details
 Table 83. Legend Biotech Business Overview
 Table 84. Legend Biotech CAR-T Therapy Product
 Table 85. Legend Biotech Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 86. Legend Biotech Recent Development
 Table 87. Atara Biotherapeutics Company Details
 Table 88. Atara Biotherapeutics Business Overview
 Table 89. Atara Biotherapeutics CAR-T Therapy Product
 Table 90. Atara Biotherapeutics Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 91. Atara Biotherapeutics Recent Development
 Table 92. Aurora Biopharma Company Details
 Table 93. Aurora Biopharma Business Overview
 Table 94. Aurora Biopharma CAR-T Therapy Product
 Table 95. Aurora Biopharma Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 96. Aurora Biopharma Recent Development
 Table 97. Autolus Therapeutics PLC Company Details
 Table 98. Autolus Therapeutics PLC Business Overview
 Table 99. Autolus Therapeutics PLC CAR-T Therapy Product
 Table 100. Autolus Therapeutics PLC Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 101. Autolus Therapeutics PLC Recent Development
 Table 102. Bluebird Company Details
 Table 103. Bluebird Business Overview
 Table 104. Bluebird CAR-T Therapy Product
 Table 105. Bluebird Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 106. Bluebird Recent Development
 Table 107. Carina Biotech Company Details
 Table 108. Carina Biotech Business Overview
 Table 109. Carina Biotech CAR-T Therapy Product
 Table 110. Carina Biotech Revenue in CAR-T Therapy Business (2020-2025) & (US$ Million)
 Table 111. Carina Biotech Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. CAR-T Therapy Picture
 Figure 2. Global CAR-T Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global CAR-T Therapy Market Share by Type: 2024 VS 2031
 Figure 4. CD19 Features
 Figure 5. CD22 Features
 Figure 6. Other Features
 Figure 7. Global CAR-T Therapy Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global CAR-T Therapy Market Share by Application: 2024 VS 2031
 Figure 9. Acute Lymphocytic Leukemia Case Studies
 Figure 10. Diffuse Large B Cell Lymphoma Case Studies
 Figure 11. Follicular Lymphoma Case Studies
 Figure 12. Chronic Lymphocytic Leukemia Case Studies
 Figure 13. Multiple Myeloma Case Studies
 Figure 14. Other Case Studies
 Figure 15. CAR-T Therapy Report Years Considered
 Figure 16. Global CAR-T Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 17. Global CAR-T Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 18. Global CAR-T Therapy Market Share by Region: 2024 VS 2031
 Figure 19. Global CAR-T Therapy Market Share by Players in 2024
 Figure 20. Global Top CAR-T Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR-T Therapy as of 2024)
 Figure 21. The Top 10 and 5 Players Market Share by CAR-T Therapy Revenue in 2024
 Figure 22. North America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. North America CAR-T Therapy Market Share by Country (2020-2031)
 Figure 24. United States CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Canada CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Europe CAR-T Therapy Market Share by Country (2020-2031)
 Figure 28. Germany CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. France CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. U.K. CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Italy CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Russia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Nordic Countries CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Asia-Pacific CAR-T Therapy Market Share by Region (2020-2031)
 Figure 36. China CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Japan CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. South Korea CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Southeast Asia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. India CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Australia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Latin America CAR-T Therapy Market Share by Country (2020-2031)
 Figure 44. Mexico CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Brazil CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Middle East & Africa CAR-T Therapy Market Share by Country (2020-2031)
 Figure 48. Turkey CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Saudi Arabia CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. UAE CAR-T Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 51. Novartis AG Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 52. Kite Pharma Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 53. Pfizer Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 54. Juno Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 55. Celgene Corporation Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 56. CARsgen Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 57. Sorrento Therapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 58. Legend Biotech Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 59. Atara Biotherapeutics Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 60. Aurora Biopharma Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 61. Autolus Therapeutics PLC Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 62. Bluebird Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 63. Carina Biotech Revenue Growth Rate in CAR-T Therapy Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String